Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (scFv4-Ig) (FVTIG-181)

Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (scFv4-Ig) is an appended IgG format, which includes four scFv moieties at the N-termini of the constant regions. It is a bivalent homodimer, in which one anti-malaria antigen scFv is fused to the CH1 domain of a heavy chain and another anti-TLR1 scFv to the CL domain of a light chain, or vice versa. The resulting leads to 2+2 antigen-binding valency. This BsAb can retarget professional antigen-presenting cells (APCs) including DCs or NK cells to malaria antigen. It is designed for the research of Malaria therapy.

Datasheet INQUIRY

Specifications

Targets

malaria antigen & TLR1

Type

Appended IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Malaria

Targets

Target 1

malaria antigen

Alternative Names

malaria antigen; parasitic protozoans

Target 2

TLR1

Gene ID

7096

UniProt ID

Q15399

Alternative Names

CD281; TIL; TIL. LPRS5; rsc786; TLR1; Toll-like receptor 1; TLR

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "malaria antigen & TLR1"

See other bsAb targets related to "malaria antigen"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (scFv4-Ig) (FVTIG-181). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (scFv4-Ig) (CAT#: FVTIG-181)

Specifications

Targets

Customer Reviews and Q&As